Todea Doina, Herescu Andreea
Iuliu Haţieganu University of Medicine and Pharmacy Cluj-Napoca, Romania. Pneumophthisiology Clinical Hospital, Cluj-Napoca, Romania.
Clujul Med. 2013;86(1):10-5. Epub 2013 Feb 4.
The obstructive sleep apnea syndrome (OSAS) is a highly prevalent disorder, associated with recurring episodes of partial or complete upper airway occlusion during sleep, which results in marked sleep disturbance, excessive daytime sleepiness, irritability and morning headache, among other symptoms. Sleep apnea is strongly associated with impaired neuropsychological function and reduced quality of life and social functioning. Daytime sleepiness leads to an increased risk for traffic and industrial accidents. OSAS is also independently associated with several cardiovascular complications: not only systemic hypertension but also ischaemic heart disease and stroke. Identifying patients "at risk" and treating them is very important, but at the same time it is time consuming and expensive. Nevertheless, treatment with continuous positive airway pressure (CPAP) has been shown to improve symptoms and quality of life, decrease traffic accidents and may have a positive effect on cardiovascular morbidity. That is why the economic aspects of sleep apnea and the current legislation are an important issue to discuss and manage, for both the patients and the society they live in.
阻塞性睡眠呼吸暂停综合征(OSAS)是一种高度流行的疾病,与睡眠期间反复出现的部分或完全上呼吸道阻塞发作有关,这会导致明显的睡眠障碍、日间过度嗜睡、易怒和晨起头痛等症状。睡眠呼吸暂停与神经心理功能受损、生活质量下降和社会功能减退密切相关。日间嗜睡会增加交通事故和工业事故的风险。OSAS还与多种心血管并发症独立相关:不仅包括系统性高血压,还包括缺血性心脏病和中风。识别“高危”患者并对其进行治疗非常重要,但同时这既耗时又昂贵。然而,持续气道正压通气(CPAP)治疗已被证明可改善症状和生活质量,减少交通事故,并且可能对心血管发病率产生积极影响。这就是为什么睡眠呼吸暂停的经济方面以及现行立法对于患者及其所处社会来说都是一个需要讨论和管理的重要问题。